ライフサイエンスコーパス: prosthetic

1 ntal to the development of a visual cortical prosthetic.

2 : skin-attachable electronics, robotics, and prosthetics.

3 of surrounding environment for robotics and prosthetics.

4 te the development of robotics, haptics, and prosthetics.

5 nal or subcutaneous microphones for auditory prosthetics.

6 ides a new logic for enhanced-acuity retinal prosthetics.

7 al to the design of effective auditory brain prosthetics.

8 stic imitation of human skin in robotics and prosthetics.

9 or network-can thus aid the future design of prosthetics(7), robot grasping tools and human-robot int

10 nce of a BSTD, defined as an exposure of the prosthetic abutment, the implant neck or the implant sur

11 nd will ultimately, lead to a higher rate of prosthetic acceptance/use and a better level of motor pr

12 ptimal placement of the implant demonstrated prosthetic acuity of 20/460 to 20/550, and the patient w

13 he most commonly used (18)F protein-labeling prosthetic agent N-succinimidyl 3-(18)F-fluorobenzoate (

14 vestigated the cortical interactions between prosthetic and natural vision based on visually evoked p

15 These results support the idea of combined prosthetic and natural vision in restoration of sight fo

16 Using this model, where prosthetic and natural vision information are combined i

17 Clinical recommendations pertaining to the prosthetic and surgical management of each type of PMMD,

18 logies have serious limitations for advanced prosthetic and therapeutic applications due primarily to

19 onics and energy harvesting devices to smart prosthetics and human-machine interfaces.

20 n, conversion and harvesting, soft robotics, prosthetics and optomechanics.

21 hat can be applied to bio-inspired robotics, prosthetics and rehabilitation medicine, while also prov

22 preliminary results demonstrate that emotion prosthetics and somatosensory interfaces offer new possi

23 otor commands are sent from the brain to the prosthetic, and feedback rate indicates how often visual

24 uch as in minimally invasive surgery, active prosthetics, and automation tasks involving delicate irr

25 ve garments, skin-like sensors for robots or prosthetics, and user interfaces in contaminated environ

26 er trunk angular acceleration induced by the prosthetic ankle which acted to lean the trunk ipsilater

27 fully modify T cell surfaces and function as prosthetic antigen receptors (PARs) allowing selective t

28 1 [3%] vs three [1%]) and moderate or severe prosthetic aortic regurgitation (34 [9%] vs ten [3%]) we

29 acement (AVR), reoperation to relieve severe prosthetic aortic stenosis (PAS) is increasing.

30 Recently commercialized powered prosthetic arm systems hold great potential in restoring

31 mputer cursors or high-performance motorized prosthetic arms and hands.

32 Brain-computer interface (BCI) controlled prosthetic arms are being developed to restore function

33 Conventional prosthetic arms suffer from poor controllability and lac

34 e poor quality of vision returned by retinal prosthetics by reducing the signal-to-noise ratio of pro

35 These findings demonstrate that a brain prosthetic can produce coherent percepts of visual forms

36 mulation, with future applications in neural prosthetics, chip scale neural engineering, and extensio

37 Unlike typical photoreceptors employing a prosthetic chromophore to capture photons, LITE-1 strict

38 Three prosthetic complications (all fracture of veneer materia

39 Twelve prosthetic complications occurred in the NDI group and o

40 were implant and FPD failures, biologic and prosthetic complications, and marginal bone loss.

41 SDIs, although NDIs showed a higher risk of prosthetic complications.

42 ion with or without exposure of transmucosal prosthetic components or the implant fixture surface.

43 lth and establishing control interfaces with prosthetics, computer systems and wearable robotic devic

44 ons in social media and personal engagement, prosthetic control and feedback, and gaming and entertai

45 s needed for designing biologically inspired prosthetic control strategies.

46 myographic control is a robust and intuitive prosthetic control strategy.

47 monstrated application possibilities include prosthetic control with sensory feedback, monitors, and

48 ability of movement information and enhanced prosthetic control.

49 with limb amputations is crucial to improve prosthetic control.

50 BPVT was associated with re-BPVT and early prosthetic degeneration in a significant number of patie

51 ated at initial placement, implant uncovery, prosthetic delivery, and 3 to 6, 7 to 11, and 12 to 18 m

52 At time of prosthetic delivery, mesial aspect implant position was

53 s in disease investigations, drug discovery, prosthetic design and neuropathic pain investigations.

54 f implantable therapeutic devices-oculomotor prosthetics-designed to modify eye movements dynamically

55 skin flora, is an opportunist, often causing prosthetic device infections.

56 nction of a missing or paralyzed limb with a prosthetic device that acts and feels like one's own lim

57 r implant (CI) is the most successful neural prosthetic device to date and has restored hearing in hu

58 pacity to provide high fidelity control of a prosthetic device, force feedback, and natural proprioce

59 activity of cortical neurons and movement of prosthetic devices [1-4].

60 infections after arthroplasty in uncemented prosthetic devices and, simultaneously, help the fight a

61 a major obstacle in the rapid absorption of prosthetic devices by the brain.

62 such as pacemakers, implantable sensors, or prosthetic devices in hybrids of living and non-living s

63 Current prosthetic devices suffer from the limitation of low spa

64 This phenomenon might be exploited in novel prosthetic devices to enhance their control, thus ultima

65 or the development of new sensory and neural prosthetic devices which are capable of more precise poi

66 onality and bidirectional communication with prosthetic devices.

67 nt infections of the bloodstream, bones, and prosthetic devices.

68 tant consideration in the design of cortical prosthetic devices.SIGNIFICANCE STATEMENT Understanding

69 noncardiac death, no other mortality, and no prosthetic dysfunction, and MR remained absent in all tr

70 oundations for using technology as cognitive prosthetics even during neurodegenerative illnesses.

71 rocedures, which present similar implant and prosthetic failure rates but greater morbidity.

72 other for the primary outcomes (implant and prosthetic failure).

73 and intensity of plantar pressures under the prosthetic feet of two transtibial amputees.

74 When fitting prosthetic feet, prosthetists fuse information from thei

75 For prosthetic finger control, regression-based methods are

76 amputation walked on the variable-stiffness prosthetic foot set to a randomized stiffness, while sev

77 ssess patient and prosthetist preference for prosthetic foot stiffness using a custom variable-stiffn

78 monkey research is the development of neural prosthetics for assisting paralyzed patients.

79 s with [(18)F]fluoride require (18)F-labeled prosthetics for bioconjugation more often with cysteine

80 europsychiatric illness; powerful control of prosthetics for restorative function in degenerative dis

81 st-guest interactions to endow proteins with prosthetic functionality.

82 In addition to robotics and prosthetics, future applications include smart textiles

83 alve dysfunction (BVD), defined as increased prosthetic gradient >=10 mm Hg or new gradient >=20 mm H

84 nhance the design and performance of a novel prosthetic graft, which utilises internal ridge(s) to in

85 Prosthetic grafts and patches are commonly used in cardi

86 was produced by a 2-step procedure with the prosthetic group 6-(18)F-fluoronicotinic acid 2,3,5,6-te

87 rostatic interactions of a compound with the prosthetic group allows the prediction of inhibitory pot

88 metabolism (12% of genes), and cofactor and prosthetic group biosynthesis (8% of genes).

89 ly on using traditional metal ion chelate or prosthetic group chemistries.

90 tated the distance between the catalytic MIO prosthetic group created from (189)Ala-Ser-Gly(191) resi

91 eme (iron protoporphyrin IX) is a well-known prosthetic group for enzymes involved in metabolic pathw

92 Heme is an essential prosthetic group in proteins that reside in virtually ev

93 Haem is an essential prosthetic group of numerous proteins and a central sign

94 We also demonstrate that the heme B prosthetic group present at the subunit dimer interface

95 ization: 1) conformational distortion of the prosthetic group retinal, and 2) charge separation betwe

96 We identified MYFR as a prosthetic group that is tightly, but noncovalently, bou

97 atalases/peroxidases that depend on the heme prosthetic group to afford peroxide reduction and thiol-

98 fluoro-2-pentafluorophenyl naphthoate (PFPN) prosthetic group was synthesized to incorporate fluorine

99 lable fluorescent dye (via an amine-reactive prosthetic group), and rapid and efficient radiolabeling

100 monooxygenases, contains a tightly bound FAD prosthetic group, and is required for the stereoselectiv

101 rrier protein (MdcC subunit) with a distinct prosthetic group, as well as decarboxylase (MdcD-MdcE) a

102 s synthesis featured fluorination of a novel prosthetic group, followed by a copper-free click conjug

103 the Phe residue is positioned over the heme prosthetic group.

104 f lysozyme, a well-studied protein lacking a prosthetic group.

105 opharmaceuticals, creating new chelators and prosthetic groups for radiolabeling.

106 esponsible for generating these Fe-S cluster prosthetic groups in Escherichia coli Although Isc domin

107 ith the binding of dioxygen (O2) to the heme prosthetic groups of the globin chains: from paramagneti

108 : PSMA-targeting probes with trifluoroborate prosthetic groups represent promising candidates for pro

109 Nitrogenase harbors three distinct metal prosthetic groups that are required for its activity.

110 pectral characteristics of PE are due to its prosthetic groups, or phycoerythrobilins (PEBs), that ar

111 ss Fe(2+) or Fe/S complexes as co-factors or prosthetic groups.

112 ed for bidirectional communication between a prosthetic hand and electrodes implanted in the nerves a

113 erson with transradial amputation identified prosthetic hand postures using artificial somatosensory

114 Technological advances in multi-articulated prosthetic hands have outpaced the development of method

115 designing control algorithms for myoelectric prosthetic hands in the future.

116 of amputation or spinal cord injury can use prosthetic hands to restore their independence.

117 restoration in the next generation of neuro-prosthetic hands.

118 trends in the device development for neural prosthetics have focused on establishing stimulus locali

119 .60; 95% confidence interval [CI], 1.6-8.0), prosthetic heart valve (HR, 6.2; 95% CI, 3.8-10.1), male

120 Risk factors for IE were prosthetic heart valve (odds ratio [OR]: 3.93; 95% CI: 1

121 ptake on PET/CT in patients with noninfected prosthetic heart valve (PHV).

122 Prosthetic heart valve interventions continue to evolve

123 ion aid to support shared decision making in prosthetic heart valve selection does not lower decision

124 Dutch online patient decision aid to support prosthetic heart valve selection was recently developed.

125 in optimization of shared decision making in prosthetic heart valve selection.

126 y or invasive procedure in the past 30 days, prosthetic heart valve, and higher number of positive bl

127 faecalis bacteremia, community acquisition, prosthetic heart valve, and male sex are associated with

128 od cells (RBCs) passing through heart pumps, prosthetic heart valves and other cardiovascular devices

129 ndations for the management of patients with prosthetic heart valves in these areas of controversy.

130 n guidelines for management of patients with prosthetic heart valves with the 2017 European Society o

131 Those with prosthetic heart valves, significant mitral stenosis, an

132 )/Fe(II) couple, and we demonstrate that the prosthetic heme group is post-translationally modified a

133 Presently, the use of prosthetic hiatal herniorrhaphy for large hiatal hernia

134 ive RCTs comparing suture cruroplasty versus prosthetic hiatal herniorrhaphy for large hiatal hernia

135 osthetic knees were affected more often than prosthetic hips (78%).

136 Existing methods for testing prosthetic implants suffer from critical limitations, cr

137 romising approaches include optogenetics and prosthetic implants, which aim to bypass lost photorecep

138 movement provided the foundation for neural prosthetics in which brain-controlled interfaces are use

139 as an effective sensory channel to transmit prosthetic information to the brain or between brains, a

140 Demographic, medical, surgical, and prosthetic information was recorded.

141 Early prosthetic intervention should revive this process.

142 5 cases and iris adenoma in 1 case underwent prosthetic iris device implantation surgery.

143 either residual iris or opaque portions of a prosthetic iris device.

144 Prosthetic iris implantation was combined with phacoemul

145 e indicates how often visual feedback of the prosthetic is provided to the subject.

146 culture in 97 sonication fluid samples from prosthetic joint and other orthopedic device infections.

147 g the microbial etiology of culture-negative prosthetic joint infection (PJI) can be challenging.

148 ecently demonstrated improved sensitivity of prosthetic joint infection (PJI) diagnosis using an auto

149 lant sonication culture for the diagnosis of prosthetic joint infection (PJI) has improved sensitivit

150 Accurate and rapid diagnosis of prosthetic joint infection (PJI) is vital for rational a

151 Treatment of prosthetic joint infection (PJI) usually requires surgic

152 or hospitalized infection within 30 days and prosthetic joint infection (PJI) within 1 year after sur

153 eus is a leading cause of biofilm-associated prosthetic joint infection (PJI), resulting in considera

154 in sonicate fluid, providing a diagnosis of prosthetic joint infection (PJI).

155 re subsequently revised for an indication of prosthetic joint infection between 2003 and 2014, after

156 and the procedures subsequently revised for prosthetic joint infection between 2003 and 2014.

157 tified several risk factors for revision for prosthetic joint infection following knee replacement.

158 ese factors with the risk of revision due to prosthetic joint infection following primary knee replac

159 Prosthetic joint infection is a devastating complication

160 The risk of developing a prosthetic joint infection is affected by patient, surgi

161 Its role in diabetic pedal osteomyelitis and prosthetic joint infection is not established.

162 uate power, and does not differentiate early prosthetic joint infection, most likely related to the i

163 31, 2014) or until the date of revision for prosthetic joint infection, revision for another indicat

164 could lead to a reduced risk of revision for prosthetic joint infection.

165 care system factors and risk of revision for prosthetic joint infection.

166 e associated with lower risk of revision for prosthetic joint infection.

167 thout any significant impact on incidence of prosthetic joint infection.

168 clinical features, and treatment options for prosthetic joint infection.

169 ensitive and specific diagnosis of S. aureus prosthetic joint infection.

170 ssociated with a higher risk of revision for prosthetic joint infection.

171 Peri-prosthetic joint infections (PJI) are a serious adverse

172 ld standard for microbiological diagnosis of prosthetic joint infections (PJI).

173 Prosthetic joint infections are difficult to diagnose an

174 inical outcomes of total joint replacements, prosthetic joint infections still remain a significant c

175 Prosthetic joint infections were excluded.

176 c antibiotics are not recommended to prevent prosthetic joint infections.

177 ophylaxis for prevention of endocarditis and prosthetic joint infections.

178 laxis for the prevention of endocarditis and prosthetic joint infections.

179 c antibiotics are not recommended to prevent prosthetic joint infections.

180 Many are for prophylaxis in patients with prosthetic joint replacements; the American Dental Socie

181 Many are for prophylaxis in patients with prosthetic joint replacements; the American Dental Socie

182 Aseptic loosening is a major complication of prosthetic joint surgery, characterized by chronic infla

183 Prosthetic joints are at risk of becoming infected durin

184 f hematogenous PJI, concomitant asymptomatic prosthetic joints have a very low risk of being infected

185 s) PJI between 2005-2015 who had concomitant prosthetic joints in situ.

186 als dislodged from the surfaces of explanted prosthetic joints using sonication.

187 with a hematogenous PJI and 108 concomitant prosthetic joints were included.

188 Infected prosthetic joints were younger than the non-infected one

189 Of the 95 asymptomatic prosthetic joints, 1 PJI developed during the follow-up

190 Of 108 concomitant prosthetic joints, 13 were symptomatic, of which 10 were

191 s: 9 endoleak corrections, 1 open repair for prosthetic kink, and 10 distal extensions of the graft t

192 res can achieve uniform surface heating of a prosthetic knee joint.

193 n the non-infected ones in 67% of cases, and prosthetic knees were affected more often than prostheti

194 For robotics and prosthetics, large-area integration on 3D surfaces in a

195 Prosthetic leaflet thrombosis was detected in 1 patient

196 t, terminal illness, inflammatory arthritis, prosthetic leg, cognitive impairment, lack of a telephon

197 However, safe and reliable prosthetic-limb control strategies for robust ambulation

198 s, has potential as an approach to sensorize prosthetic limbs.

199 ntrol realistic high-dimensional articulated prosthetic limbs.

200 , mediated through the disulfide bond of the prosthetic lipoyl moiety.

201 an follow-up at 39.3 (20 to 56) months since prosthetic loading, all 65 implants were functional (100

202 psoriatic arthritis, periodontitis and peri-prosthetic loosening.

203 hitening and advanced restorative as well as prosthetic materials and techniques, supported by the pi

204 moderate or severe mitral valve stenosis or prosthetic mechanical heart valves, treatment options in

205 Percutaneous closure of prosthetic mitral valve paravalvular leak (PVL) has emer

206 regularly shaped flexure bearings, compliant prosthetics, morphing structures, and soft robots.

207 sex; education; people living in the house; prosthetic needs; or number of decayed, missing, or fill

208 For prosthetics, neural interfacing electrodes are of high i

209 luence of the linker and the trifluoroborate prosthetic on pharmacokinetics and image quality.

210 tions will make it possible to extend neural prosthetic paradigms to precise interaction with objects

211 tions are increasing, and the options of the prosthetic pathways are currently evolving.

212 Both implant-supported prosthetic pathways represent a valuable treatment optio

213 No prosthetic problem was observed.

214 y the periodontitis and assign a periodontal/prosthetic prognosis.

215 Four patients had prosthetic re-intervention and no difference was found f

216 Higher rates of prosthetic regurgitation and pacemaker implantation were

217 smoking, implant location, sex, and type of prosthetic rehabilitation.

218 ree males and 12 females, who required fixed prosthetic rehabilitation.

219 defects, and the PV is usually the site for prosthetic replacement following a Ross operation.

220 A aortic dissections are often treated with prosthetic replacement of the ascending aorta.

221 Hemiarthroplasty (prosthetic replacement of the femoral head) fixation via

222 hat included mucous membrane grafting (MMG), prosthetic replacement of the ocular surface ecosystem (

223 ics by reducing the signal-to-noise ratio of prosthetic responses.

224 yperactivity can improve optogenetic retinal prosthetic responses.

225 982) and the interaction between the type of prosthetic restoration and the amount of residual corona

226 l was to assess the influence of the type of prosthetic restoration as well as the degree of hard tis

227 = 60) were defined depending on the type of prosthetic restoration needed: 1) single unit porcelain-

228 Degree of hard tissue loss and type of final prosthetic restoration should be carefully considered wh

229 plications for disease management, including prosthetic restoration strategies.

230 a more favorable environment for the future prosthetic restoration with implants.

231 The crude cumulative 2-y risk of requiring prosthetic (risk difference [RD], 0.21) and endodontic (

232 The running-specific prosthetic (RSP) configuration used by athletes with tra

233 These prosthetics seek to mimic natural activity patterns to a

234 rocess by providing two mappings between the prosthetic sensor and the location of the sensory percep

235 The trunk and prosthetic-side leg contributions to H at toe-off when u

236 this new technology into neural stimulation prosthetics, such as cochlear implants for the deaf, wit

237 Potential applications include prosthetics, surgical robots, and wearable devices, as w

238 including bilaminar techniques, the combined prosthetic-surgical approach or soft tissue augmentation

239 owed significant differences between the two prosthetic techniques in favor of using DAs.

240 Retinal prosthetics that can restore vision in animal models may

241 ecessary for the proper function of cochlear prosthetics, therefore, it is of great interest to under

242 ns to Co, Cr and Ti by analysing viable peri-prosthetic tissue.

243 ical correction by using vertical expandable prosthetic titanium rib (VEPTR).

244 Conclusion Vertical expandable prosthetic titanium rib operation was associated with po

245 s a promising approach in rehabilitation and prosthetics to model the series of transformations from

246 alysis of body fluids, (ii) smart gloves and prosthetics to realise the sensation of touch and pain,

247 rs before and after IR, and the surgical and prosthetic treatments offered after IR was assessed.

248 omyography-based control is congruent with a prosthetic user's innate proprioception of muscle deform

249 proprioceptive sonomyographic control with 5 prosthetic users and 5 able-bodied participants in a vir

250 the absence of tactile sensory information, prosthetic users must rely on incidental visual and audi

251 In fact, prosthetic users often cite "difficulty of use" as a key

252 at with limited training, the performance of prosthetic users was comparable to that of able-bodied p

253 such as SMA, as well as for next generation prosthetics, utilizing in vitro phenotypic models would

254 TAVR patients had larger prosthetic valve area (1.7 cm(2) vs. 1.2 cm(2), p<0.001)

255 re recruited into 2 cohorts with and without prosthetic valve dysfunction and underwent in vivo contr

256 the prognostic value of (18)F-FDG PET/CT in prosthetic valve endocarditis (PVE) and native valve end

257 Prosthetic valve endocarditis (PVE) is a rare but critic

258 In non-operated prosthetic valve endocarditis (PVE), long term outcome i

259 In nonoperated prosthetic valve endocarditis (PVE), long-term outcome i

260 ed in the subgroups of patients with NVE and prosthetic valve endocarditis (PVE)/ascending aortic pro

261 13, over 100 cases of Mycobacterium chimaera prosthetic valve endocarditis and disseminated disease w

262 the case of a 75-year-old German woman with prosthetic valve endocarditis due to Bartonella washoens

263 s for PET were oncology (n=26), suspicion of prosthetic valve endocarditis subsequently excluded (n=1

264 rn approach to cardiac imaging in native and prosthetic valve endocarditis, as well as cardiac implan

265 cently acknowledged as a diagnostic tool for prosthetic valve endocarditis, but its specificity is li

266 sdiagnosed IE particularly in the setting of prosthetic valve endocarditis, paravalvular extension of

267 rion for the diagnosis of device-related and prosthetic valve endocarditis, that addition has not bee

268 ed when interpreting FDG PET/CT in suspected prosthetic valve endocarditis, with specific attention t

269 PVE is an established mechanism of prosthetic valve failure post-SAVR and TAVR with unclear

270 was markedly lower for native valve IE than prosthetic valve IE and cardiac implantable electronic d

271 , especially in the challenging scenarios of prosthetic valve IE and cardiac implantable electronic d

272 remains diagnostically imperfect in cases of prosthetic valve IE or cardiac implantable electronic de

273 of IE and its subgroups of native valve IE, prosthetic valve IE, and cardiac implantable electronic

274 Native and prosthetic valve IE, infections relating to cardiac impl

275 and specificity 0.98 (0.95-0.99, 34.4%); for prosthetic valve IE: sensitivity 0.86 (0.81-0.89, 60.0%)

276 t occurs in 5-17% of patients after surgical prosthetic valve implantation.

277 re routine surveillance within 3 years after prosthetic valve insertion (73 [17.1%]), routine surveil

278 At least one prosthetic valve leaflet with grade 3 or higher motion r

279 the percentage of patients with at least one prosthetic valve leaflet with grade 3 or higher motion r

280 quiring repeat procedure, moderate or severe prosthetic valve regurgitation, or prosthetic valve sten

281 or severe prosthetic valve regurgitation, or prosthetic valve stenosis within 30 days of the procedur

282 of aspirin, use of fibrinolytic therapy for prosthetic valve thrombosis, and management of paravalvu

283 blood culture bottles, native valve disease, prosthetic valve, previous IE, and cardiac device.

284 adient >=5 mm Hg or area <=1.5 cm(2) and [2] prosthetic valve: resting mean MV gradient >=5 mm Hg or

285 s 17; P=0.046) and had a better knowledge of prosthetic valves (85% versus 68%; P=0.004).

286 inconclusive, particularly in patients with prosthetic valves (PVs) and implantable cardiac electron

287 ical differences, EE more frequently affects prosthetic valves and less frequently pacemakers/defibri

288 anticoagulation for atrial fibrillation, and prosthetic valves are vital therapeutic adjuncts.

289 infective endocarditis (IE) in patients with prosthetic valves or implantable devices.

290 rtic root enlargement, supra-annular stented prosthetic valves, stentless bioprosthesis, and suturele

291 303 episodes of left-sided suspected IE (188 prosthetic valves/ascending aortic prosthesis and 115 na

292 ns in the development of long-term pixelated prosthetic vision for future devices.

293 It could transform the current prosthetic vision landscape by leading in a new directio

294 Prosthetic vision was assessed by mapping light percepti

295 ilarities in the interactions of natural and prosthetic vision, including similar effect of backgroun

296 ients with the proper placement of the chip, prosthetic visual acuity was only 10% to 30% less than t

297 All 5 patients could perceive white-yellow prosthetic visual patterns with adjustable brightness in

298 fields such as healthcare, robotic systems, prosthetics, visual realities, professional sports, ente

299 g implies that, with current methods, visual prosthetics will have a limited dynamic range available

300 on, P3HT NPs provide a new avenue in retinal prosthetics with potential applications not only in reti